AP
Antipodes Partners Portfolio holdings
AUM
$4.76B
1-Year Est. Return
35.04%
This Fund
S&P 500
1 Year Est. Return
+35.04%
AUM
$4.46B
AUM Growth
+$1.23B
(+38%)
Holding
137
Top Buys
| 1 | +$176M | |
| 2 | +$160M | |
| 3 | +$151M | |
| 4 |
Ameren
AEE
|
+$143M |
| 5 |
Essential Utilities
WTRG
|
+$128M |
Top Sells
| 1 | +$126M | |
| 2 | +$93M | |
| 3 | +$82.1M | |
| 4 |
Johnson Controls International
JCI
|
+$60.6M |
| 5 |
UBS Group
UBS
|
+$54.9M |
Sector Composition
| 1 | Utilities | 29.1% |
| 2 | Healthcare | 12.44% |
| 3 | Technology | 11.97% |
| 4 | Financials | 8.08% |
| 5 | Materials | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
argenx
ARGX
$50.8B
| $212K | ﹤0.01% |
287
-45
|
|
||
77
Tidewater
TDW
$3.14B
| $179K | ﹤0.01% |
+3,362
|
|
||
78
PubMatic
PUBM
$291M
| $158K | ﹤0.01% |
+19,065
|
|
||
79
Certara
CERT
$1.18B
| $150K | ﹤0.01% |
12,285
+5,620
|
|
||
80
Immunome
IMNM
$2.65B
| $128K | ﹤0.01% |
10,892
+631
|
|
||
81
Structure Therapeutics
GPCR
$5.17B
| $114K | ﹤0.01% |
4,078
+1,146
|
|
||
82
Abbott
ABT
$190B
| $111K | ﹤0.01% |
828
+87
|
|
||
|
CHYM
83
Chime Financial
CHYM
$7.78B
| $109K | ﹤0.01% |
5,402
+402
|
|
||
84
DexCom
DXCM
$27.3B
| $109K | ﹤0.01% |
1,617
+773
|
|
||
85
Schrodinger
SDGR
$953M
| $98.5K | ﹤0.01% |
4,912
+3,660
|
|
||
86
Steris
STE
$23.9B
| $87.1K | ﹤0.01% |
352
+92
|
|
||
87
Cencora
COR
$68.5B
| $83.1K | ﹤0.01% |
266
+62
|
|
||
88
Transocean
RIG
$5.44B
| $77.5K | ﹤0.01% |
+24,838
|
|
||
89
Qiagen
QGEN
$10.6B
| $68.2K | ﹤0.01% |
1,526
-1,040
|
|
||
90
MYR Group
MYRG
$3.93B
| $62.6K | ﹤0.01% |
301
-403
|
|
||
91
Establishment Labs
ESTA
$1.93B
| $53.6K | ﹤0.01% |
1,307
-741
|
|
||
92
Natera
NTRA
$27.5B
| $53.1K | ﹤0.01% |
330
+17
|
|
||
93
Thermo Fisher Scientific
TMO
$204B
| $47.5K | ﹤0.01% |
+98
|
|
||
94
908 Devices
MASS
$224M
| $45.8K | ﹤0.01% |
5,227
-1,331
|
|
||
95
Henry Schein
HSIC
$9.06B
| $41.9K | ﹤0.01% |
632
+46
|
|
||
96
GE Aerospace
GE
$321B
| $41.2K | ﹤0.01% |
137
-94
|
|
||
97
Ingersoll Rand
IR
$37.9B
| $40.2K | ﹤0.01% |
486
+173
|
|
||
98
iRhythm Holdings
IRTC
$4.73B
| $37.8K | ﹤0.01% |
220
-35
|
|
||
99
Oric Pharmaceuticals
ORIC
$970M
| $34.8K | ﹤0.01% |
2,901
-2,293
|
|
||
100
Nuvalent
NUVL
$7.84B
| $33.8K | ﹤0.01% |
391
-88
|
|